Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 April 2024 | Story ANTHONY MTHEMBU | Photo Stephen Collet
His Excellency Dr Reuben E Brigety II
His Excellency Dr Reuben E Brigety II presenting his guest lecture at the Centenary Complex.

The University of the Free State (UFS) recently had the honour of hosting a thought-provoking guest lecture delivered by His Excellency Dr Reuben E Brigety II, the United States Ambassador to South Africa. Held on 23 April 2024 at the Centenary Complex, on the UFS Bloemfontein campus, the lecture delved into the vital role of higher education in fostering and safeguarding democracies.

Describing the occasion as a pivotal moment for the institution, Prof Francis Petersen, Vice-Chancellor and Principal of the UFS, articulated, "Having the United States Ambassador to South Africa visit our institution and deliver this guest lecture presents an invaluable opportunity. It allows us to gain unique insights into the parallel dynamics and challenges facing our sister democracies, particularly as both our countries approach significant electoral periods.”

Dr Brigety, in his address, underscored the significance of higher education in the context of Freedom Day, celebrated in South Africa on 27 April 2024. He emphasised the role universities play in advancing democratic values, drawing upon the UFS motto, “In truth is the light of wisdom” to elucidate this connection. Highlighting the inspirational figure of the late Charlotte Maxeke, a prominent social and political activist, Dr Brigety noted her pivotal role in both South African and American contexts.

Maxeke, a graduate of Wilberforce University, and her husband Marshall Maxeke, founded the Wilberforce Community College upon returning to South Africa. Dr Brigety underscored the significance of Maxeke’s commitment to civil liberties and education, along with her enduring ties to the Wilberforce University network, in shaping subsequent generations of activists and leaders.

Moreover, Dr Brigety stressed the importance of collaborative efforts between South African and American universities amidst today’s complex global challenges. He advocated for initiatives such as collaborative research projects, joint academic programmes, and student exchanges, citing their role not only in knowledge creation but also in fostering mutual understanding and strengthening bilateral relations.

In concluding his address, Dr Brigety urged the audience to emulate the examples set by individuals like Charlotte Maxeke and Prof Jonathan Jansen, the former Rector and Vice-Chancellor of UFS. He encouraged them to champion the cultivation of the next generation of leaders, thinkers, and change-makers. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept